Skip to content

Author

Donato Gemmati

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Epigenetics in Alzheimer’s disease: from molecular mechanisms to emerging novel biomarkers

Alzheimer’s disease (AD) is an age-related progressive neurodegenerative disorder that represents the leading cause of dementia worldwide, affecting over 50 million people. This global burden is expected to rise dramatically over the coming decades because of global population aging, representing a public health concer...

Elisabetta D'Aversa, Miriana Grisafi, Salvatore Pernagallo et al. · 0 citations
Review Open access Jul 2026

Non-Coding RNAs in Cancer Liquid Biopsy: From Regulatory Networks to Functional Biomarkers for Precision Oncology

It is proposed that ncRNAs should not be viewed as alternatives to ctDNA, but as potential functional biomarkers that can link tumor genotype, regulatory state, and clinical phenotype within integrated multi-analyte precision oncology.

Salvatore Pernagallo, Veronica Tisato, Donato Gemmati · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.